Intravoxel incoherent motion magnetic resonance imaging for breast cancer: A comparison with benign lesions and evaluation of heterogeneity in different tumor regions with prognostic factors and molecular classification

Zhao,Ming; Fu,Kuang; Zhang,Lei; Guo,Wenhui; Wu,Qiong; Bai,Xue; Li,Ziyao; Guo,Qiang; Tian,Jiawei

doi:10.3892/ol.2018.9312

Intravoxel incoherent motion magnetic resonance imaging for breast cancer: A comparison with benign lesions and evaluation of heterogeneity in different tumor regions with prognostic factors and molecular classification

Authors:
- Ming Zhao
- Kuang Fu
- Lei Zhang
- Wenhui Guo
- Qiong Wu
- Xue Bai
- Ziyao Li
- Qiang Guo
- Jiawei Tian
View Affiliations

Affiliations: Department of MRI Diagnosis, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China, Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China
Published online on: August 16, 2018 https://doi.org/10.3892/ol.2018.9312
Pages: 5100-5112
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The objective of the present study was to compare the differentiation between breast cancer and benign breast lesions and study regional distribution characteristics in various subtypes of breast cancer using intravoxel incoherent motion (IVIM) parameters. This retrospective study involved 119 patients with breast cancer and 22 patients with benign breast lesions, who underwent 3.0T breast magnetic resonance imaging examinations. The apparent diffusion coefficient (ADC) and IVIM parameters (slow ADC, fast ADC and fraction of fast ADC) were obtained from patients with breast cancer and benign lesions using diffusion‑weighted imaging (DWI) with b‑values of 0, 50, 100, 150, 200, 400, 500, 1,000 and 1,500 sec/mm2. Compared with patients with benign breast lesions, patients with breast cancer exhibited decreased ADC (P<0.001), slow ADC (P<0.001) and fast ADC (P<0.001) values, and higher fraction of fast ADC (P<0.001) values. Tumors with metastatic axillary lymph nodes demonstrated increased fraction of fast ADC values (P<0.001) and decreased slow ADC values (P<0.001) compared with tumors without metastatic axillary lymph nodes. The Fast ADC values of tumor tissues in estrogen receptor (ER) and progesterone receptor (PR) negative groups were higher than in positive groups (P<0.001), and the slow ADC values of tumor tissues were lower in ER and PR negative groups than positive groups (P<0.001). Luminal B (HER2‑ negative) tumor (P<0.001) and peritumor (P<0.001) tissues exhibited decreased fraction of fast ADC values, in comparison with other subtypes. Triple‑negative breast cancer (TNBC) tumor tissue exhibited increased fast ADC (P<0.001) and fraction of fast ADC values (P<0.001), and decreased slow ADC values (P<0.001), when compared with other subtypes. The TNBC tumor edge tissues had increased fraction of fast ADC values compared with other subtypes (P<0.01) and TNBC tumor tissues (P<0.05). Therefore, the IVIM parameters of tumor, tumor edge and peritumor tissues in various subtypes of breast cancer may be useful for differentiation of breast cancer subtypes and to assess the invasive extent of the tumors.

View Figures

View References

1	Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO and Kennecke H: Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol. 28:1684–1691. 2010. View Article : Google Scholar : PubMed/NCBI
2	Ades F, Zardavas D, Bozovic-Spasojevic I, Pugliano L, Fumagalli D, de Azambuja E, Viale G, Sotiriou C and Piccart M: Luminal B breast cancer: Molecular characterization, clinical management, and future perspectives. J Clin Oncol. 32:2794–2803. 2014. View Article : Google Scholar : PubMed/NCBI
3	Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, et al: Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 101:736–750. 2009. View Article : Google Scholar : PubMed/NCBI
4	Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B and Senn HJ: Panel members: Strategies for subtypes-dealing with the diversity of breast cancer: Highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol. 22:1736–1747. 2011. View Article : Google Scholar : PubMed/NCBI
5	Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thürlimann B and Senn HJ; Panel members, : Personalizing the treatment of women with early breast cancer: Highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol. 24:2206–2223. 2013. View Article : Google Scholar : PubMed/NCBI
6	Boisserie-Lacroix M, Hurtevent-Labrot G, Ferron S, Lippa N, Bonnefoi H and Mac Grogan G: Correlation between imaging and molecular classification of breast cancers. Diagn Interv Imaging. 94:1069–1080. 2013. View Article : Google Scholar : PubMed/NCBI
7	Mazurowski MA, Zhang J, Grimm LJ, Yoon SC and Silber JI: Radiogenomic analysis of breast cancer: Luminal B molecular subtype is associated with enhancement dynamics at MR imaging. Radiology. 273:365–372. 2014. View Article : Google Scholar : PubMed/NCBI
8	Aberle DR, Chiles C, Gatsonis C, Hillman BJ, Johnson CD, McClennan BL, Mitchell DG, Pisano ED, Schnall MD and Sorensen AG; American College of Radiology Imaging Network, : Imaging and cancer: Research strategy of the american college of radiology imaging network. Radiology. 235:741–751. 2005. View Article : Google Scholar : PubMed/NCBI
9	Zhang L, Li J, Xiao Y, Cui H, Du G, Wang Y, Li Z, Wu T, Li X and Tian J: Identifying ultrasound and clinical features of breast cancer molecular subtypes by ensemble decision. Sci Rep. 5:110852015. View Article : Google Scholar : PubMed/NCBI
10	Brandao AC, Lehman CD and Partridge SC: Breast magnetic resonance imaging: Diffusion-weighted imaging. Magn Reson Imaging Clin N Am. 21:321–336. 2013. View Article : Google Scholar : PubMed/NCBI
11	Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, Dzik-Jurasz A, Ross BD, Van Cauteren M, Collins D, et al: Diffusion-weighted magnetic resonance imaging as a cancer biomarker: Consensus and recommendations. Neoplasia. 11:102–125. 2009. View Article : Google Scholar : PubMed/NCBI
12	Basser PJ: Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed. 8:333–344. 1995. View Article : Google Scholar : PubMed/NCBI
13	Woodhams R, Ramadan S, Stanwell P, Sakamoto S, Hata H, Ozaki M, Kan S and Inoue Y: Diffusion-weighted imaging of the breast: Principles and clinical applications. Radiographics. 31:1059–1084. 2011. View Article : Google Scholar : PubMed/NCBI
14	Atuegwu NC, Arlinghaus LR, Li X, Welch EB, Chakravarthy BA, Gore JC and Yankeelov TE: Integration of diffusion-weighted MRI data and a simple mathematical model to predict breast tumor cellularity during neoadjuvant chemotherapy. Magn Reson Med. 66:1689–1696. 2011. View Article : Google Scholar : PubMed/NCBI
15	Yoshikawa MI, Ohsumi S, Sugata S, Kataoka M, Takashima S, Mochizuki T, Ikura H and Imai Y: Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med. 26:222–226. 2008. View Article : Google Scholar : PubMed/NCBI
16	Squillaci E, Manenti G, Di Roma M, Miano R, Palmieri G and Simonetti G: Correlation of diffusion-weighted MR imaging with cellularity of renal tumours. Anticancer Res. 24:4175–4179. 2004.PubMed/NCBI
17	Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW and Lehman CD: Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol. 193:1716–1722. 2009. View Article : Google Scholar : PubMed/NCBI
18	Sinha S, Lucas-Quesada FA, Sinha U, DeBruhl N and Bassett LW: In vivo diffusion-weighted MRI of the breast: Potential for lesion characterization. J Magn Reson Imaging. 15:693–704. 2002. View Article : Google Scholar : PubMed/NCBI
19	Fornasa F, Pinali L, Gasparini A, Toniolli E and Montemezzi S: Diffusion-weighted magnetic resonance imaging in focal breast lesions: Analysis of 78 cases with pathological correlation. Radiol Med. 116:264–275. 2011. View Article : Google Scholar : PubMed/NCBI
20	Malayeri AA, El Khouli RH, Zaheer A, Jacobs MA, Corona-Villalobos CP, Kamel IR and Macura KJ: Principles and applications of diffusion weighted imaging in cancer detection, staging, and treatment follow-up. Radiographics. 31:1773–1791. 2011. View Article : Google Scholar : PubMed/NCBI
21	Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E and Laval-Jeantet M: MR imaging of intravoxel incoherent motions: Application to diffusion and perfusion in neurologic disorders. Radiology. 161:401–407. 1986. View Article : Google Scholar : PubMed/NCBI
22	Koh DM, Collins DJ and Orton MR: Intravoxel incoherent motion in body diffusion weighted MRI: Reality and challenges. AJR Am J Roentgenol. 196:1351–1361. 2011. View Article : Google Scholar : PubMed/NCBI
23	Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J and Laval-Jeantet M: Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 168:497–505. 1988. View Article : Google Scholar : PubMed/NCBI
24	Suo S, Lin N, Wang H, Zhang L, Wang R, Zhang S, Hua J and Xu J: Intravoxel incoherent motion diffusion-weighted MR imaging of breast cancer at 3.0 tesla: Comparison of different curve-fitting methods. J Magn Reson Imaging. 42:362–370. 2015. View Article : Google Scholar : PubMed/NCBI
25	Kim Y, Ko K, Kim D, Min C, Kim SG, Joo J and Park B: Intravoxel incoherent motion diffusion-weighted MR imaging of breast cancer: Association with histopathological features and subtypes. Br J Radiol. 89:201601402016. View Article : Google Scholar : PubMed/NCBI
26	Sigmund EE, Cho GY, Kim S, Finn M, Moccaldi M, Jensen JH, Sodickson DK, Goldberg JD, Formenti S and Moy L: Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer. Magn Reson Med. 65:1437–1447. 2011. View Article : Google Scholar : PubMed/NCBI
27	Meacham CE and Morrison SJ: Tumour heterogeneity and cancercell plasticity. Nature. 501:328–337. 2013. View Article : Google Scholar : PubMed/NCBI
28	Fisher R, Pusztai L and Swanton C: Cancer heterogeneity: Implications for targeted therapeutics. Br J Cancer. 108:479–485. 2013. View Article : Google Scholar : PubMed/NCBI
29	Polyak K: Heterogeneity in breast cancer. J Clin Invest. 121:3786–3788. 2011. View Article : Google Scholar : PubMed/NCBI
30	Iima M, Yano K, Kataoka M, Umehana M, Murata K, Kanao S, Togashi K and Le Bihan D: Quantitative non-gaussian diffusion and intravoxel incoherent motion magnetic resonance imaging: Differentiation of malignant and benign breast lesions. Invest Radiol. 50:205–211. 2015. View Article : Google Scholar : PubMed/NCBI
31	Liu C, Liang C, Liu Z, Zhang S and Huang B: Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: Comparison with conventional DWI. Eur J Radiol. 82:e782–e789. 2013. View Article : Google Scholar : PubMed/NCBI
32	Cho GY, Moy L, Kim SG, Baete SH, Moccaldi M, Babb JS, Sodickson DK and Sigmund EE: Evaluation of breast cancer using intravoxel incoherent motion (IVIM) histogram analysis: Comparison with malignant status, histological subtype, and molecular prognostic factors. Eur Radiol. 26:2547–2558. 2016. View Article : Google Scholar : PubMed/NCBI
33	Alili C, Pages E, Curros Doyon F, Perrochia H, Millet I and Taourel P: Correlation between MR imaging-prognosis factors and molecular classification of breast cancers. Diagn Interv Imag. 95:235–242. 2014. View Article : Google Scholar
34	Uematsu T, Kasami M and Yuen S: Triple-negative breast cancer: Correlation between MR imaging and pathologic findings. Radiology. 250:638–647. 2009. View Article : Google Scholar : PubMed/NCBI
35	Cho GY, Gennaro L, Sutton EJ, Zabor EC, Zhang Z, Giri D, Moy L, Sodickson DK, Morris EA, Sigmund EE and Thakur SB: Intravoxel incoherent motion(IVIM) histogram biomarkers for prediction of neoadjuvant treatment response in breast cancer patients. Eur J Radiol Open. 4:101–107. 2017. View Article : Google Scholar : PubMed/NCBI
36	Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, et al: Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology/college of American pathologists clinical practice guideline update. Arch Pathol Lab Med. 138:241–256. 2014. View Article : Google Scholar : PubMed/NCBI
37	Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathhol. 147:9–19. 1995.
38	Liu C, Wang K, Chan Q, Liu Z, Zhang J, He H, Zhang S and Liang C: Intravoxel incoherent motion MR imaging for breast lesions: Comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging. Eur Radiol. 26:3888–3898. 2016. View Article : Google Scholar : PubMed/NCBI
39	Bokacheva L, Kaplan JB, Giri DD, Patil S, Gnanasigamani M, Nyman CG, Deasy JO, Morris EA and Thakur SB: Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma. J Magn Reson Imaging. 40:813–823. 2014. View Article : Google Scholar : PubMed/NCBI
40	Sigmund EE, Cho GY, Kim S, Finn M, Moccaldi M, Jensen JH, Sodickson DK, Goldberg JD, Formenti S and Moy L: Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer. Magn Reson Med. 65:1437–1447. 2011. View Article : Google Scholar : PubMed/NCBI
41	Jeh SK, Kim SH, Kim HS, Kang BJ, Jeong SH, Yim HW and Song BJ: Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma. J Magn Reson Imaging. 33:102–109. 2011. View Article : Google Scholar : PubMed/NCBI
42	Kamitani T, Matsuo Y, Yabuuchi H, Fujita N, Nagao M, Jinnouchi M, Yonezawa M, Yamasaki Y, Tokunaga E, Kubo M, et al: Correlations between apparent diffusion coefficient values and prognostic factors of breast cancer. Magn Reson Med Sci. 12:193–199. 2013. View Article : Google Scholar : PubMed/NCBI
43	Kim SH, Cha ES, Kim HS, Kang BJ, Choi JJ, Jung JH, Park YG and Suh YJ: Diffusion-weighted imaging of breast cancer: Correlation of the apparent diffusion coefficient value with prognostic factors. J Magn Reson Imaging. 30:615–620. 2009. View Article : Google Scholar : PubMed/NCBI
44	Huuse EM, Moestue SA, Lindholm EM, Bathen TF, Nalwoga H, Krüger K, Bofin A, Maelandsmo GM, Akslen LA, Engebraaten O and Gribbestad IS: In vio MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts. J Magn Reson Imaging. 35:1098–1107. 2012. View Article : Google Scholar : PubMed/NCBI
45	Zhang SJ, Hu Y, Qian HL, Jiao SC, Liu ZF, Tao HT and Han L: Expression and significance of ER, PR, VEGF, CA15-3, CA125 and CEA in judging the prognosis of breast cancer. Asian Pac J Cancer Prev. 14:3937–3940. 2013. View Article : Google Scholar : PubMed/NCBI
46	Noh S, Kim do H, Jung WH and Koo JS: Expression levels of serine/glycine metabolishm-realted proteins in triple negative breast cancer tissues. Tumor Biol. 35:4457–4468. 2014. View Article : Google Scholar
47	Biesaga B, Niemiec J and Ziobro M: Microvessel density and status of p53 protein as potential prognostic factors for adjuvant anthracycline chemotherapy in restrospective analysis of early breast cancer patients group. Pathol Oncol Res. 18:949–960. 2012. View Article : Google Scholar : PubMed/NCBI
48	Dai X, Chen A and Bai Z: Integrative investigation on breast cancer in ER, PR, and HER2-defined subgroups using mRNA and miRNA expression profiling. Sci Rep. 4:65662014. View Article : Google Scholar : PubMed/NCBI
49	Mori N, Ota H, Mugikura S, Takasawa C, Ishida T, Watanabe G, Tada H, Watanabe M, Takase K and Takahashi S: Luminal-type breast cancer: Correlation of apparent diffusion coefficients with the Ki-67 labeling index. Radiology. 274:66–73. 2015. View Article : Google Scholar : PubMed/NCBI
50	Holowatyj AN, Ruterbusch JJ, Ratnam M, Gorski DH and Cote ML: HER2 status and disparities in luminal breast cancers. Cancer Med. 5:2109–2116. 2016. View Article : Google Scholar : PubMed/NCBI
51	Uematsu T: MR imaging of triple-negative breast cancer breast cancer. Breast Cancer. 18:161–164. 2011. View Article : Google Scholar : PubMed/NCBI
52	Vranic S, Frkovic-Grazio S, Bilalovic N and Gatalica Z: Angiogenesis in triple-negativeadenoid cystic carcinomas of the breast. Virchows Arch. 459:377–382. 2011. View Article : Google Scholar : PubMed/NCBI